teaser
↓Article continues below this sponsored advert↓
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE
↑Advertisement↑
Roche has presented yet more positive data from the third late-stage study of its experimental compound for rheumatoid arthritis, Actemra
